We recently reported that vasopressin analogues correct the in vitro vascular hyporeactivity to adrenergic vasoconstrictors in portal hypertensive rats. The aim of the present study was to determine whether vasopressin reduces splanchnic blood flow in portal vein-ligated (PVL) rats by restoring vasoconstrictor responsiveness in vivo. The ultrasonic transit time-shift technique was used for blood flow measurements. At basal conditions, blood flow through the superior mesenteric artery was elevated 1.6-fold in PVL rats as compared with sham-operated (SHAM) control rats. PVL rats also exhibited blunted mesenteric constrictor responses to the adrenoceptor agonist, phenylephrine (0.03-1 mol · min ؊1 · kg ؊1 ). Terlipressin (2-20 g · kg ؊1 ) and arginine vasopressin (3-300 pmol · min ؊1 · kg ؊1 ) dosedependently reduced, and at the highest doses, even abolished, the difference in mesenteric blood flow (MBF) between PVL and SHAM rats. When expressed as percent changes relative to baseline, mesenteric arterial responses to terlipressin and arginine vasopressin were found to be enhanced in PVL rats as compared with SHAM rats. Moreover, pretreatment with terlipressin (20 g · kg ؊1 ) reversed the mesenteric hyporesponsiveness to phenylephrine of PVL rats. These vasopressin effects were independent of the nitric oxide (NO) pathway, because they were not mimicked by inhibition of NO synthesis with N G -nitro-Larginine methyl ester (L-NAME) (0.1-10 mg · kg ؊1 ). These data indicate that pharmacological doses of vasopressin reverse the splanchnic hyperemia by restoring the responsiveness to adrenergic vasoconstrictors in portal hypertensive rats. (HEPATOLOGY 1998;28:646-654.)Portal hypertension is associated with hyperdynamic circulation, which is characterized by decreased peripheral resistance and increased cardiac output. Although vasodilation is present in most vascular beds, it is especially important in the splanchnic circulation. Blood flow to the abdominal organs in portal hypertension is about twice as high as under normal conditions, 1,2 a fact that has been shown to be responsible for the maintenance of chronically elevated portal pressure. 2,3 Several possible explanations for the splanchnic vasodilation have been raised, including circulating vasodilators, decreased reactivity of the splanchnic arteries to endogenous vasoconstrictors, and/or local overproduction of vasodilator mediators such as nitric oxide (NO), of which evidence for its involvement has increasingly accumulated. 4,5 Vasopressin analogues are currently used in the treatment of acute variceal bleeding in cirrhotic patients, because they effectively reduce splanchnic blood flow, and thus portal pressure as well. [6][7][8] In addition, ornipressin has been shown to normalize systemic and renal hemodynamics and renal function in decompensated cirrhosis. 9 We recently provided data that vasopressin analogues reverse the vascular hyporeactivity to adrenoceptor stimulation in isolated perfused mesenteric arterial beds of portal hypertensive rats. 10,11 T...